Guidant ACS Multi-Link Duet
This article was originally published in The Gray Sheet
Executive Summary
Company files a premarket approval application supplement for rapid exchange and over-the-wire versions of the next-generation coronary stent, Guidant reports May 19. The Duet, an RX version of which was launched in select international markets following receipt of a CE mark Feb. 19 ("The Gray Sheet" March 9, p. 12), offers enhanced radiopacity and deliverability, the firm claims. The PMA supplement seeks approval for the Duet with 8, 13, 18, 23 and 28 mm lengths and 3-4 mm diameters. The wide range of lengths and diameters will allow physicians to treat a broader range of pathologies, Guidant says
You may also be interested in...
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.